Patents matching “formulation”

US 11433025

Oil foamable carriers and formulations

Vyne Therapeutics Inc. · Granted Sep 6, 2022 · Expires Sep 1, 2042

US 11433029

Formulation of an antibody and use thereof

Takeda Pharmaceutical Company Limited · Granted Sep 6, 2022 · Expires Sep 1, 2042

US 11426418

Injectable long-acting semi-solid gel formulations

MIRA PHARMA CORPORATION · Granted Aug 30, 2022 · Expires Aug 25, 2042

US 11427540

Formulations of T-type calcium channel modulators and methods of use thereof

PRAXIS PRECISION MEDICINES, INC. · Granted Aug 30, 2022 · Expires Aug 25, 2042

US 11426486

Chitosan-containing formulations

PRIMEX EHF · Granted Aug 30, 2022 · Expires Aug 25, 2042

US 11426446

Stable aqueous formulations of aflibercept

Coherus BioSciences, Inc. · Granted Aug 30, 2022 · Expires Aug 25, 2042

US 11420931

Lipid containing formulations

ARBUTUS BIOPHARMA CORPORATION · Granted Aug 23, 2022 · Expires Aug 18, 2042

US 11406713

Xanthine oxidase inhibitor formulations

XORTX THERAPEUTICS, INC. · Granted Aug 9, 2022 · Expires Aug 4, 2042

US 11407649

Cerium (III) carbonate formulations

The Regents of the University of California · Granted Aug 9, 2022 · Expires Aug 4, 2042

US 11400052

Alcohol-resistant drug formulations

Jazz Pharmaceuticals Ireland Limited · Granted Aug 2, 2022 · Expires Jul 28, 2042

US 11389473

Magnesium-containing oxytocin formulations and methods of use

TONIX PHARMACEUTICALS HOLDING CORP · Granted Jul 19, 2022 · Expires Jul 14, 2042

US 11370787

Pyrazole compounds, formulations thereof, and a method for using the compounds and/or formulations

Rigel Pharmaceuticals, Inc. · Granted Jun 28, 2022 · Expires Jun 23, 2042

US 11364215

GHB formulation and method for its manufacture

Jazz Pharmaceuticals Ireland Limited · Granted Jun 21, 2022 · Expires Jun 16, 2042

US 11364293

Compositions and methods for making and using thermostable immunogenic formulations with increased compatibility of use as vaccines against one or more pathogens

The Regents of the University of Colorado · Granted Jun 21, 2022 · Expires Jun 16, 2042

US 11364251

Pharmaceutical formulation

Semnur Pharmaceuticals, Inc. · Granted Jun 21, 2022 · Expires Jun 16, 2042

US 11351120

Use of higher doses of modified release huperzine formulations

Supernus Pharmaceuticals, Inc. · Granted Jun 7, 2022 · Expires Jun 2, 2042

US 11351124

Sustained release of formulations of local anesthetics

Eupraxia Pharmaceuticals Inc. · Granted Jun 7, 2022 · Expires Jun 2, 2042

US 11345904

Targeted therapeutic lysosomal enzyme fusion proteins, associated formulations and uses thereof

BIOMARIN PHARMACEUTICAL INC. · Granted May 31, 2022 · Expires May 26, 2042

US 11318100

Storage stable sincalide formulations

MAIA PHARMACEUTICALS, INC. · Granted May 3, 2022 · Expires Apr 28, 2042

US 11311581

Combination comprising spirulina and palmitoylethanolamide and/or salts or pharmaceutically acceptable derivatives thereof and their formulations, for use in the prevention and/or in the treatment of hyperactivated tissue conditions

AGAIN LIFE ITALIA SRL · Granted Apr 26, 2022 · Expires Apr 21, 2042

US 11311547

Antiviral prodrugs and nanoformulations thereof

BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Apr 26, 2022 · Expires Apr 21, 2042

US 11311532

High dosage valbenazine formulation and compositions, methods, and kits related thereto

Neurocrine Biosciences, Inc. · Granted Apr 26, 2022 · Expires Apr 21, 2042

US 11291672

Betamethasone oral spray formulation and method of use to treat ataxia

GRACE THERAPEUTICS INC. · Granted Apr 5, 2022 · Expires Mar 31, 2042

US 11291728

Anhydrous sodium thiosulfate and formulations thereof

Fennec Pharmaceuticals, Inc. · Granted Apr 5, 2022 · Expires Mar 31, 2042